Skip to content

Effects of different doses of remimazolam on postoperative recovery of gynecological total hysterectomy

Effects of different doses of remimazolam on postoperative recovery of gynecological total hysterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119258
Enrollment
Unknown
Registered
2026-02-25
Start date
2026-02-25
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Sponsors

Suzhou Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Preoperative diagnosis confirmed by ultrasound/MRI imaging as gynecological diseases meeting the International Federation of Gynecology and Obstetrics (FIGO) classification criteria requiring surgical treatment; 2. American Society of Anesthesiologists (ASA) Physical Status Classification I-II; 3. Age 30 to 60 years;

Exclusion criteria

Exclusion criteria: 1.BMI >= 30 kg/m^²; 2. Active systemic inflammation (CRP >10 mg/L) or microbiologically confirmed acute pelvic inflammatory disease; 3. Cirrhosis (Child-Pugh class B/C) or chronic kidney disease (eGFR = 3 months).

Design outcomes

Primary

MeasureTime frame
Quality of Recovery-15;Post-induction hypotension incidence rate;

Secondary

MeasureTime frame
Vital signs;Wake-up time;Extubation time;PACU time;Additional medication use;Cough intensity grading during extubation;Adverse reactions during and 24 hours after surgery;

Countries

China

Contacts

Public ContactFen Yang

Suzhou Municipal Hospital

w123_78_77@126.com+86 159 9570 8339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026